•
Sep 30, 2023

iTeos Therapeutics Q3 2023 Earnings Report

EPS
-$0.9
Previous year: $0.03
-3100.0%
Gross Profit
-$224K
Previous year: $19.3M
-101.2%
Cash and Equivalents
$599M
Previous year: $752M
-20.4%
Free Cash Flow
-$34.6M
Previous year: -$29.8M
+16.3%
Total Assets
$678M
Previous year: $778M
-12.9%

iTeos Therapeutics

iTeos Therapeutics